Zydus Lifesciences on Saturday announced the launch of Semaglutide Injection in India under the brand names SEMAGLYN™, MASHEMA™ and ALTERME™, following patent expiry.
The National on MSN
The next health boom after Ozempic? Inside the world of self-injectable pens
As GLP-1 drugs make home-administered jabs commonplace, others in the wellness space are adopting the method ...
The presenters will also highlight the unmet need and market opportunity driving PharmaJet’s expansion into the self-injection pen market. Dr. Wouter Latour, CEO of PharmaJet, will present Reusable ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in people with ...
LG Chem is introducing a new Utropin product equipped with an upgraded pen injector, aiming to expand treatment options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results